Literature DB >> 23853567

Status cataplecticus precipitated by abrupt withdrawal of venlafaxine.

Janice Wang1, Harly Greenberg.   

Abstract

Status cataplecticus is a rare manifestation of narcolepsy with cataplexy episodes recurring for hours or days, without a refractory period, in the absence of emotional triggers. This case highlights a narcoleptic patient who developed status cataplecticus after abrupt withdrawal of venlafaxine.

Entities:  

Keywords:  Status cataplecticus; cataplexy; narcolepsy; venlafaxine withdrawal

Mesh:

Substances:

Year:  2013        PMID: 23853567      PMCID: PMC3671338          DOI: 10.5664/jcsm.2848

Source DB:  PubMed          Journal:  J Clin Sleep Med        ISSN: 1550-9389            Impact factor:   4.062


  6 in total

Review 1.  Control of motoneuron function and muscle tone during REM sleep, REM sleep behavior disorder and cataplexy/narcolepsy.

Authors:  J Peever
Journal:  Arch Ital Biol       Date:  2011-12-01       Impact factor: 1.000

2.  Status cataplecticus misdiagnosed as recurrent syncope.

Authors:  R S Calabrò; R Savica; A Laganà; A Magaudda; D Imbesi; G Gallitto; P La Spina; R Musolino
Journal:  Neurol Sci       Date:  2008-01-04       Impact factor: 3.307

3.  Excessive daytime sleepiness and the pathophysiology of narcolepsy-cataplexy: a laboratory perspective.

Authors:  R Broughton; V Valley; M Aguirre; J Roberts; W Suwalski; W Dunham
Journal:  Sleep       Date:  1986       Impact factor: 5.849

4.  Exacerbation of human cataplexy by prazosin.

Authors:  M S Aldrich; A E Rogers
Journal:  Sleep       Date:  1989-06       Impact factor: 5.849

5.  Exacerbation of cataplexy following gradual withdrawal of antidepressants: manifestation of probable protracted rebound cataplexy.

Authors:  Ruzica K Ristanovic; Howard Liang; Carl S Hornfeldt; Chinglin Lai
Journal:  Sleep Med       Date:  2008-08-26       Impact factor: 3.492

6.  Sodium oxybate demonstrates long-term efficacy for the treatment of cataplexy in patients with narcolepsy.

Authors: 
Journal:  Sleep Med       Date:  2004-03       Impact factor: 3.492

  6 in total
  8 in total

Review 1.  Neurobiological and immunogenetic aspects of narcolepsy: Implications for pharmacotherapy.

Authors:  Steven T Szabo; Michael J Thorpy; Geert Mayer; John H Peever; Thomas S Kilduff
Journal:  Sleep Med Rev       Date:  2018-11-08       Impact factor: 11.609

2.  Narcolepsy Type 1 and Idiopathic Generalized Epilepsy: Diagnostic and Therapeutic Challenges in Dual Cases.

Authors:  Simone Baiardi; Stefano Vandi; Fabio Pizza; Lara Alvisi; Lucia Toscani; Elena Zambrelli; Paolo Tinuper; Geert Mayer; Giuseppe Plazzi
Journal:  J Clin Sleep Med       Date:  2015-11-15       Impact factor: 4.062

Review 3.  Cataplexy and Its Mimics: Clinical Recognition and Management.

Authors:  Sigrid Pillen; Fabio Pizza; Karlien Dhondt; Thomas E Scammell; Sebastiaan Overeem
Journal:  Curr Treat Options Neurol       Date:  2017-06       Impact factor: 3.598

Review 4.  Challenges in the development of therapeutics for narcolepsy.

Authors:  Sarah Wurts Black; Akihiro Yamanaka; Thomas S Kilduff
Journal:  Prog Neurobiol       Date:  2015-12-23       Impact factor: 11.685

5.  Pseudo Status Cataplecticus in Narcolepsy Type 1.

Authors:  Candace N Meinen; Kelsey M Smith; Jan-Mendelt Tillema; Suresh Kotagal
Journal:  J Clin Sleep Med       Date:  2018-09-15       Impact factor: 4.062

Review 6.  Treatment paradigms for cataplexy in narcolepsy: past, present, and future.

Authors:  Todd J Swick
Journal:  Nat Sci Sleep       Date:  2015-12-11

Review 7.  A practical guide to the pharmacological and behavioral therapy of Narcolepsy.

Authors:  Christian Franceschini; Fabio Pizza; Francesca Cavalli; Giuseppe Plazzi
Journal:  Neurotherapeutics       Date:  2021-04-22       Impact factor: 7.620

8.  Withdrawal Symptoms Following Discontinuation of Vortioxetine-Retrospective Chart Review.

Authors:  Marcin Siwek; Adrian Andrzej Chrobak; Aleksandra Gorostowicz; Anna Julia Krupa; Dominika Dudek
Journal:  Pharmaceuticals (Basel)       Date:  2021-05-11
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.